• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry.通过流式细胞术检测分枝杆菌特异性CD4和CD8 T细胞免疫的全血细胞内细胞因子染色试验的鉴定
J Immunol Methods. 2015 Feb;417:22-33. doi: 10.1016/j.jim.2014.12.003. Epub 2014 Dec 16.
2
Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants.在婴儿接种牛分枝杆菌卡介苗后,多功能CD4 T细胞与体外分枝杆菌生长抑制相关。
Vaccine. 2016 Oct 17;34(44):5298-5305. doi: 10.1016/j.vaccine.2016.09.002. Epub 2016 Sep 9.
3
Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies.全血细胞内细胞因子检测法在现场研究中定量特定T细胞频率的新应用。
J Immunol Methods. 2004 Aug;291(1-2):185-95. doi: 10.1016/j.jim.2004.06.010.
4
Patterns of intracellular cytokines in CD4 and CD8 T cells from patients with mycobacterial infections.分枝杆菌感染患者CD4和CD8 T细胞内细胞因子的模式。
Braz J Med Biol Res. 2004 Aug;37(8):1119-29. doi: 10.1590/s0100-879x2004000800003. Epub 2004 Jul 20.
5
Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.卡介苗接种可增强人类γδ T细胞对分枝杆菌的反应性,提示存在记忆样表型。
J Immunol. 1998 Jul 15;161(2):1045-54.
6
Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.T细胞功能的衰退以及抑制性标志物的同时上调与卡介苗诱导的小鼠抗结核保护作用的减弱相对应。
PLoS One. 2014 Nov 24;9(11):e113951. doi: 10.1371/journal.pone.0113951. eCollection 2014.
7
The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).一种35型腺病毒载体结核病疫苗在CD4(+) T细胞计数>350个细胞/mm(3)的HIV感染且接种过卡介苗的成人中的安全性和免疫原性。
Vaccine. 2015 Apr 8;33(15):1890-6. doi: 10.1016/j.vaccine.2015.02.004. Epub 2015 Feb 17.
8
Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.潜伏和活动性结核中 Rv2204c、Rv0753c 和 Rv0009 抗原特异性 T 细胞应答:基于流式细胞术的分析。
Int J Med Microbiol. 2018 Mar;308(2):297-305. doi: 10.1016/j.ijmm.2017.12.001. Epub 2017 Dec 6.
9
Standardization of cryopreserved peripheral blood mononuclear cells through a resting process for clinical immunomonitoring--Development of an algorithm.通过静息过程对冷冻保存的外周血单个核细胞进行标准化用于临床免疫监测——一种算法的开发
Cytometry A. 2016 Mar;89(3):246-58. doi: 10.1002/cyto.a.22813. Epub 2016 Feb 5.
10
The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses.新型结核病疫苗AERAS-402在先前接种过卡介苗的健康婴儿中是安全的,并能诱导剂量依赖性的CD4和CD8 T细胞反应。
Vaccine. 2014 Oct 14;32(45):5908-17. doi: 10.1016/j.vaccine.2014.09.001. Epub 2014 Sep 10.

引用本文的文献

1
Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humans.ID93+GLA-SE 疫苗接种诱导的固有和适应性免疫反应的共调节。
Front Immunol. 2024 Sep 24;15:1441944. doi: 10.3389/fimmu.2024.1441944. eCollection 2024.
2
Whole Blood Reactivity to Viral and Bacterial Pathogens after Non-Emergent Cardiac Surgery during the Acute and Convalescence Periods Demonstrates a Distinctive Profile of Cytokines Production Compared to the Preoperative Baseline in Cohort of 108 Patients, Suggesting Immunological Reprogramming during the 28 Days Traditionally Recognized as the Post-Surgical Recovery Period.108例患者队列中,非急诊心脏手术后急性期和恢复期全血对病毒和细菌病原体的反应性与术前基线相比,显示出细胞因子产生的独特特征,提示在传统上被认为是术后恢复期的28天内存在免疫重编程。
Biomedicines. 2023 Dec 21;12(1):28. doi: 10.3390/biomedicines12010028.
3
Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy.评价腺相关病毒为基础的基因治疗的细胞免疫反应。
AAPS J. 2023 Apr 26;25(3):47. doi: 10.1208/s12248-023-00814-5.
4
A whole blood intracellular cytokine assay optimised for field site studies demonstrates polyfunctionality of CD4+ T cells in acute scrub typhus.一种优化用于现场研究的全血细胞内细胞因子检测方法显示,急性丛林斑疹伤寒中 CD4+ T 细胞具有多功能性。
PLoS Negl Trop Dis. 2023 Mar 24;17(3):e0010905. doi: 10.1371/journal.pntd.0010905. eCollection 2023 Mar.
5
A semi high-throughput whole blood-based flow cytometry assay to detect and monitor -specific Th1, Th2 and Th17 responses.一种半高通量全血流式细胞术检测和监测特异性 Th1、Th2 和 Th17 反应的方法。
Front Immunol. 2023 Feb 6;14:1101366. doi: 10.3389/fimmu.2023.1101366. eCollection 2023.
6
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults.BCG 疫苗对 COVISHIELD™ 疫苗诱导 SARS-CoV-2 血清阴性印度年轻成年人免疫应答的异源获益证据。
Front Immunol. 2022 Oct 4;13:985938. doi: 10.3389/fimmu.2022.985938. eCollection 2022.
7
Durable Expansion of TCR-δ Meta-Clonotypes After BCG Revaccination in Humans.BCG 复种后人类 TCR-δ 元克隆型的持久扩增。
Front Immunol. 2022 Mar 30;13:834757. doi: 10.3389/fimmu.2022.834757. eCollection 2022.
8
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis.类风湿关节炎患者接种SARS-CoV-2 mRNA疫苗6个月后B细胞和T细胞免疫反应的动力学
Front Immunol. 2022 Feb 28;13:846753. doi: 10.3389/fimmu.2022.846753. eCollection 2022.
9
BCG revaccination qualitatively and quantitatively enhances SARS-CoV-2 spike-specific neutralizing antibody and T cell responses induced by the COVISHIELD vaccine in SARS-CoV-2 seronegative young Indian adults.在新冠病毒血清阴性的年轻印度成年人中,卡介苗再接种在质量和数量上增强了由科维希德疫苗诱导的新冠病毒刺突蛋白特异性中和抗体和T细胞反应。
Res Sq. 2022 Mar 2:rs.3.rs-1395683. doi: 10.21203/rs.3.rs-1395683/v1.
10
A 2-Dose AERAS-402 Regimen Boosts CD8 Polyfunctionality in HIV-Negative, BCG-Vaccinated Recipients.两剂 AERAS-402 方案增强了 HIV 阴性、BCG 接种受者的 CD8 多能性。
Front Immunol. 2021 Jun 11;12:673532. doi: 10.3389/fimmu.2021.673532. eCollection 2021.

本文引用的文献

1
Preventive vaccines for tuberculosis.结核预防性疫苗。
Vaccine. 2013 Apr 18;31 Suppl 2:B223-6. doi: 10.1016/j.vaccine.2012.11.081.
2
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.新型结核疫苗 MVA85A 在既往接种过卡介苗婴儿中的安全性和有效性:一项随机、安慰剂对照的 2b 期试验。
Lancet. 2013 Mar 23;381(9871):1021-8. doi: 10.1016/S0140-6736(13)60177-4.
3
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.新型结核疫苗 M72/AS01 在南非成年人中诱导和调节 T 细胞免疫。
Am J Respir Crit Care Med. 2013 Aug 15;188(4):492-502. doi: 10.1164/rccm.201208-1385OC.
4
Prospects for tuberculosis elimination.结核病消除的前景。
Annu Rev Public Health. 2013;34:271-86. doi: 10.1146/annurev-publhealth-031912-114431. Epub 2012 Dec 14.
5
A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.一项新的结核病疫苗 MVA85A 在 HIV 和/或结核分枝杆菌感染成人中的 IIa 期临床试验。
Am J Respir Crit Care Med. 2012 Apr 1;185(7):769-78. doi: 10.1164/rccm.201108-1548OC. Epub 2012 Jan 26.
6
Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.在冈比亚婴儿中进行的一项随机对照试验表明,与 EPI 疫苗同时接种结核疫苗 MVA85A 会降低其免疫原性。
Sci Transl Med. 2011 Jun 22;3(88):88ra56. doi: 10.1126/scitranslmed.3002461.
7
Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.新型结核疫苗 MVA85A 在健康 BCG 疫苗接种婴儿中的剂量探索研究。
J Infect Dis. 2011 Jun 15;203(12):1832-43. doi: 10.1093/infdis/jir195.
8
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.更新的使用干扰素γ释放试验来检测结核分枝杆菌感染的指南-美国,2010 年。
MMWR Recomm Rep. 2010 Jun 25;59(RR-5):1-25.
9
Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers.Ag85B-ESAT-6 佐剂与 IC31 联合促进了初免人类志愿者中强烈和持久的结核分枝杆菌特异性 T 细胞应答。
Vaccine. 2010 Apr 30;28(20):3571-81. doi: 10.1016/j.vaccine.2010.02.094. Epub 2010 Mar 11.
10
The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults.新型结核疫苗 AERAS-402 可诱导成人产生强大且多功能的 CD4+和 CD8+T 细胞。
Am J Respir Crit Care Med. 2010 Jun 15;181(12):1407-17. doi: 10.1164/rccm.200910-1484OC. Epub 2010 Feb 18.

通过流式细胞术检测分枝杆菌特异性CD4和CD8 T细胞免疫的全血细胞内细胞因子染色试验的鉴定

Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry.

作者信息

Kagina Benjamin M, Mansoor Nazma, Kpamegan Eloi P, Penn-Nicholson Adam, Nemes Elisa, Smit Erica, Gelderbloem Sebastian, Soares Andreia P, Abel Brian, Keyser Alana, Sidibana Mzwandile, Hughes Jane E, Kaplan Gilla, Hussey Gregory D, Hanekom Willem A, Scriba Thomas J

机构信息

South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa; Vaccines for Africa Initiative, Division of Medical Microbiology & Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa.

South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease and Molecular Medicine and School of Child and Adolescent Health, University of Cape Town, South Africa; BD Biosciences, Johannesburg, South Africa.

出版信息

J Immunol Methods. 2015 Feb;417:22-33. doi: 10.1016/j.jim.2014.12.003. Epub 2014 Dec 16.

DOI:10.1016/j.jim.2014.12.003
PMID:
25523923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4339399/
Abstract

BACKGROUND

Qualified or validated assays are essential in clinical trials. Short-term stimulation of whole blood and intracellular cytokine staining assay is commonly used to measure immunogenicity in tuberculosis vaccine clinical trials. Previously, the short-term stimulation process of whole blood with BCG was optimized. We aimed to qualify the intracellular cytokine staining process and assess the effects of long-term cryopreservation. Our hypotheses were that the assay is robust in the measurement of the mycobacteria-specific T cells, and long-term cryopreservation of fixed cells from stimulated whole blood would not compromise reliable measurement of mycobacteria induced CD4 T cell immunity.

METHODS

Whole blood from healthy adults was collected in sodium heparinized tubes. The blood was left unstimulated or stimulated with mycobacterial antigens or mitogens for 12h. Cells were harvested, fixed and multiple aliquots from each participant cryopreserved. Later, mycobacteria-specific CD4 and CD8 T cells expressing IFN-γ, TNF-α, IL-2 and IL-17 were quantitated by flow cytometry. Assay performance characteristics evaluated included limit of quantification and detection, reproducibility, precision, robustness, specificity and sensitivity. To assess the effects of long-term cryopreservation, fixed cells from the stimulated bloods were analysed one week post-cryopreservation and at 3-month intervals over a 3-year period.

RESULTS

The limit of quantification for the different cytokines was variable: 0.04% for frequencies of IFN-γ- and IL-2-expressing T cells and less than 0.01% for TNF-α- and IL-17-expressing T cells. When measurement of the mycobacteria-specific T cells was assessed at levels above the detection limit, the whole blood intracellular cytokine assay showed high precision that was operator-independent. The assay was also robust: variation in staining conditions including temperature (4 °C or 20-23 °C) and time (45, 60 or 90 min) did not markedly affect quantification of specific T cells. Finally, prolonged periods of cryopreservation also did not significantly influence quantification of mycobacteria-specific CD4 T cells.

CONCLUSIONS

The whole blood intracellular cytokine assay is robust and reliable in quantification of the mycobacteria-specific T cells and is not significantly affected by cryopreservation of fixed cells.

摘要

背景

在临床试验中,合格或经过验证的检测方法至关重要。全血短期刺激和细胞内细胞因子染色检测常用于结核病疫苗临床试验中的免疫原性检测。此前,已对卡介苗对全血的短期刺激过程进行了优化。我们旨在验证细胞内细胞因子染色过程,并评估长期冷冻保存的影响。我们的假设是,该检测方法在检测分枝杆菌特异性T细胞方面具有稳健性,并且长期冷冻保存受刺激全血中的固定细胞不会影响对分枝杆菌诱导的CD4 T细胞免疫的可靠检测。

方法

将健康成年人的全血采集到肝素钠抗凝管中。血液不进行刺激或用分枝杆菌抗原或丝裂原刺激12小时。收集细胞,固定,并将每个参与者的多个等分试样冷冻保存。随后,通过流式细胞术对表达IFN-γ、TNF-α、IL-2和IL-17的分枝杆菌特异性CD4和CD8 T细胞进行定量。评估的检测性能特征包括定量限和检测限、重现性、精密度、稳健性、特异性和敏感性。为了评估长期冷冻保存的影响,在冷冻保存一周后以及在3年期间每隔3个月对受刺激血液中的固定细胞进行分析。

结果

不同细胞因子的定量限各不相同:表达IFN-γ和IL-2的T细胞频率的定量限为0.04%,表达TNF-α和IL-17的T细胞的定量限小于0.01%。当在高于检测限的水平评估分枝杆菌特异性T细胞的检测时,全血细胞内细胞因子检测显示出高度的精密度,且与操作人员无关。该检测方法也具有稳健性:染色条件的变化,包括温度(4°C或20 - 23°C)和时间(45、60或90分钟),并未显著影响特异性T细胞的定量。最后,长时间的冷冻保存也未显著影响分枝杆菌特异性CD4 T细胞的定量。

结论

全血细胞内细胞因子检测在定量分枝杆菌特异性T细胞方面具有稳健性和可靠性,并且不受固定细胞冷冻保存的显著影响。